Establishing centralized databases, similar to the WHO-Adverse Drug Reaction (ADR) database, for reporting nutraceutical-related adverse events could significantly improve real-world risk monitoring
[2] During topiramate epilepsy monotherapy trials, for daily doses of 50 mg vs
Afamelanotide Afamelanotide is described as a linear tridecapeptide and a melanocortin-1 receptor agonist
The absence of required labs and the predominantly asynchronous clinical model allows for faster onboarding and lower platform costs, but represents a lighter safety checkpoint compared to platforms like Mochi Health and Enhance.MD, or PlushCare, that require labs and live provider visits
PlexusDx's Precision Peptide Genetic Test identifies these variants to support personalized dosing discussions with your provider
Joseph said not having enough could impact groundwater ecosystems and homes that run on well water